XClose

UCL-TB

Home
Menu

World TB Day

On 24th March each year, the world commemorates the day in 1882 when Dr Robert Koch announced his discovery of Mycobacterium tuberculosis as the causative agent of tuberculosis.

We have taken this opportunity to host a one-day symposium March every year since 2010, to highlight contemporary TB research, control measures and policy initiatives, and to discuss future challenges.

Our aim is to connect with all the people in London who work on, or are affected by TB: researchers; people in surveillance, control and policy; those in diagnostics and patient care; and affected patients and communities.

These symposia have been held annually since 2010.  Since 2014, we have partnered with the LSHTM TB Centre, since 2018 with The Crick Institute, and from 2020 with Birkbeck College.


Save the Date:

World TB Day Symposium 2020

Tuesday 24th March 2020

Kennedy Lecture Theatre, UCL Institute of Child Health, 30 Guildford Street, London WC1N 1EH

On the 24th of March, the world commemorates the day in 1882 when Dr Robert Koch announced his discovery of Mycobacterium tuberculosis.

We take this opportunity each year to host a one day symposium that highlights the current TB situation in the UK and around the world, the research we are carrying out in our institutions, the people involved in managing control programmes and patient care, and the people and communities that TB affects.

Book now on Eventbrite. This event is free, and normally oversubscribed, so we request that you only book sessions you think you will be able to attend. If you book and later change your mind for any session please alter your booking so that other people may use your space. For those unable to attend in person, we will once again be live-streaming the talks online, and the link will be advertised closer to the date of the event.

We very much hope that you will be able to join us on the day, and look forward to another great symposium.


Programme

Please note that all times and talk titles are subject to change

08:30    Registration and coffee

09:10    Welcome and Introductory Remarks

09:30    Session 1: Voices from the front line: Patient, healthcare provider, and policy maker perspectives
Chair: Dr Toyin Togun (LSHTM)
Dr Virginia Bond (LSHTM) How do social and economic factors, and stigma, affect the timeliness of diagnosis and treatment adherence in Zambia?
Dr Mishal Khan (LSHTM) How can we motivate community health workers and private healthcare providers to engage more actively in managing TB?
Ms Jacqui White (UCL) TB into the 21st Century – more than just medicine
Dr Sedona Sweeney (LSHTM) Value TB – costs of rolling out TB services in 5 high burden countries
Professor Marc Lipman (UCL) IMPACT: patient experience across the UK
Panel discussion and Q&A

10:50    Coffee break

11:20    Session 2: How to Find the Missing Millions?
Chair: Dr Katharina Kranzer (LSHTM)
Dr Kwame Shanaube (ZAMBART) Four years of active case finding as part of delivering the PoPART trial in Zambia and SA
Dr Palwasha Khan (LSHTM) TB diagnosis using Xpert Ultra and culture in the “Zero-TB Karachi (Pakistan)” project – successes, challenges, and lessons learned
Dr Katherine Fielding (LSHTM) Closing the gap between diagnosed and incident TB with a system for 1-day diagnosis in Uganda
Dr Lara Goscè (UCL) E-DETECT TB in Romania
Panel discussion and Q&A

12:40    Lunch break

13:40    Session 3: Redefining Latency
Chair: Professor Mahdad Noursadeghi (UCL) Introduction
Dr Hanif Esmail (UCL) Imaging and transcriptomics in HIV/TB
Dr Pranab Haldar (University of Leicester) Diagnosing early TB in a low burden setting
Professor Anne O’Garra (The Crick Institute) The host transcriptome in TB
Professor Helen Fletcher (LSHTM) The future of TB vaccines
Panel discussion and Q&A

15:00    Coffee break

15:30    Link up with University of California, San Francisco (more information on the UCSF programme)

15:50    Session 4: Accelerating Drug Discovery & Development
Chair: Dr Dimitrios Evangelopoulos (UCL)
Dr Nick Furnham (LSHTM) Understanding the molecular consequences of mutations associated with drug resistance in TB for future drug development
Dr Luiz Carvalho (The Crick Institute) M. tuberculosis metabolism and novel antibiotic strategies
Professor Sanjib Bhakta (Birkbeck, University of London) Repurposing pain-killers: new approaches to an ancient disease
Dr Anil Koul (LSHTM) Discovery and development of Bedaquiline for treatment of drug resistant tuberculosis - role of innovation in global public health
Dr Angela Crook (UCL) Developing new drug regimens
Panel discussion and Q&A

17:10    Summary and close

17:30-19:00    Drinks reception


We are delighted that this event is sponsored by the following companies and organisations actively contributing to the control of TB, and working in partnership with researchers and control teams: Cepheid, FIND, Insmed and Oxford Immunotec.

Sponsorship by Cepheid, FIND, Insmed and Oxford Immunotec